{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T19:49:40Z","timestamp":1770061780198,"version":"3.49.0"},"reference-count":58,"publisher":"MJS Publishing, Medical Journals Sweden AB","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Oncologica"],"published-print":{"date-parts":[[2000,1]]},"DOI":"10.1080\/028418600750013357","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T12:24:36Z","timestamp":1027686276000},"page":"445-454","source":"Crossref","is-referenced-by-count":3,"title":["Use of Bisphosphonates in Skeletal Metastasis"],"prefix":"10.2340","volume":"39","author":[{"given":"Inkeri","family":"Elomaa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1183","published-online":{"date-parts":[[2009,7,8]]},"reference":[{"key":"CIT0001","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1200\/JCO.1998.16.3.1218","volume":"16","author":"Bloomfield DJ","year":"1998","journal-title":"J Clin Oncol"},{"key":"CIT0002","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1200\/JCO.1998.16.12.3890","volume":"16","author":"Body JJ","year":"1998","journal-title":"J Clin Oncol"},{"key":"CIT0003","first-page":"143","volume":"15","author":"Hurst M","year":"1999","journal-title":"A review of its use in breast cancer. Drugs Aging"},{"key":"CIT0004","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3109\/02841869509094039","volume":"34","author":"Elomaa I","year":"1995","journal-title":"Acta Oncol"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650101008"},{"key":"CIT0006","first-page":"1127","volume":"50","author":"Selander K","year":"1996","journal-title":"Mol Pharmacol"},{"key":"CIT0007","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/jbmr.5650111015","volume":"11","author":"Rogers MJ","year":"1996","journal-title":"J Bone Miner Res"},{"key":"CIT0008","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s004410050879","volume":"289","author":"Espenes A","year":"1997","journal-title":"Cell Tissue Res"},{"key":"CIT0010","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1046\/j.1365-2141.1997.2713086.x","volume":"98","author":"Shipman CM","year":"1997","journal-title":"Br J Hematol"},{"issue":"1","key":"CIT0013","first-page":"53","volume":"8","author":"Elomaa I","year":"1987","journal-title":"Treatment of skeletal disease in breast cancer: a controlled clodronate trial. Bone"},{"key":"CIT0014","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000226904","volume":"48","author":"Martoni A","year":"1991","journal-title":"Oncology"},{"key":"CIT0015","first-page":"59","volume":"11","author":"Paterson AHG","year":"1993","journal-title":"Double-blind controlled trial of oral do-dronate in patients with bone metastases from breast cancer. J Clin Oncol"},{"key":"CIT0016","first-page":"491","volume":"11","author":"Van Holten-Verzantvoort ATM, Kroon HM, Bijvoet OLM, et","year":"1993","journal-title":"Palliative pamidronate treatment in patients with bone metastases from breast cancer. J Clin Oncol"},{"key":"CIT0017","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1200\/JCO.1996.14.9.2552","volume":"14","author":"Conte PF","year":"1996","journal-title":"J Clin Oncol"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199612123352401"},{"key":"CIT0019","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1200\/JCO.1998.16.6.2038","volume":"16","author":"Hortobagyi GN","year":"1998","journal-title":"J Clin Oncol"},{"key":"CIT0020","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1200\/JCO.1999.17.3.846","volume":"17","author":"Theriault RL","year":"1999","journal-title":"J Clin Oncol"},{"key":"CIT0021","first-page":"663","volume":"19","author":"Kanis JA","year":"1996","journal-title":"Clodronate decreases the frequency of skeletal metastases in women with breast cancer. Bone"},{"key":"CIT0022","first-page":"357","volume":"339","author":"Diel IJ","year":"1998","journal-title":"Reduction in new metastases in breast cancer with adjuvant clodronate treat-ment. N Engl J Med"},{"key":"CIT0023","first-page":"a489","volume":"18","author":"Saarto T","year":"1999","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CIT0024","first-page":"a468","volume":"17","author":"Powles TJ","year":"1998","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CIT0025","first-page":"450","volume":"32","author":"van Holten-Verzantvoort ATM, Hermans J, Beex LVAM, et","year":"1996","journal-title":"Does supportive pamidronate treatment prevent or delay the first manifestation of bone metastases in breast cancer patients? Eur J Cancer"},{"issue":"1","key":"CIT0026","first-page":"64A","volume":"17","author":"Rizzoli R","year":"1992","journal-title":"Bone Miner"},{"key":"CIT0027","first-page":"1341","volume":"15","author":"Saarto T","year":"1997","journal-title":"Chemical castration induced by adjuvant CMF therapy causes a rapid bone loss which is reduced by clodronate. A randomized study in premenopausal breast cancer women. J Clin Oncol"},{"key":"CIT0028","first-page":"602","volume":"75","author":"Saarto T","year":"1997","journal-title":"Clodronate improves bone mineral density in postmenopausal breast cancer women treated with adjuvant antiestrogens. Br J Cancer"},{"key":"CIT0029","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/jnci\/90.9.704","volume":"90","author":"Powles TJ","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"CIT0030","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1200\/JCO.1997.15.3.955","volume":"15","author":"Delmas PD","year":"1997","journal-title":"J Clin Oncol"},{"key":"CIT0031","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1200\/JCO.1991.9.8.1397","volume":"9","author":"Belch AR","year":"1991","journal-title":"J Clin Oncol"},{"key":"CIT0032","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/hon.2900080104","volume":"8","author":"Merlini G","year":"1990","journal-title":"Hematol Oncol"},{"key":"CIT0033","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1159\/000218633","volume":"18","author":"Heim ME","year":"1995","journal-title":"Onkologie"},{"key":"CIT0034","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/0140-6736(92)93075-X","volume":"340","author":"Lahtinen R","year":"1992","journal-title":"Lancet"},{"key":"CIT0035","first-page":"725","volume":"87","author":"Laakso M","year":"1994","journal-title":"Subgroup and cost-benefit analy-sis of the Finnish multicentre trial of clodronate in multiple myeloma. Br J Haematol"},{"key":"CIT0036","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1365-2141.1998.00567.x","volume":"100","author":"McCloskey EV","year":"1998","journal-title":"Br J Haematol"},{"key":"CIT0037","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJM199602223340802","volume":"334","author":"Berenson JR","year":"1996","journal-title":"N Engl J Med"},{"key":"CIT0038","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1200\/JCO.1998.16.2.593","volume":"16","author":"Berenson JR","year":"1998","journal-title":"J Clin Oncol"},{"key":"CIT0039","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0022-5347(17)40597-0","volume":"141","author":"Smith JA","year":"1989","journal-title":"J Urol"},{"key":"CIT0040","first-page":"159","volume":"24","author":"Elomaa I","year":"1992","journal-title":"A controlled study in patients with metastatic prostate cancer. Preliminary report. Int Urol Nephrol"},{"key":"CIT0041","first-page":"821","volume":"29","author":"Kylm\u00e4ld T","year":"1993","journal-title":"Evaluation of the effect of oral clodronate on skeletal metastases with type I collagen metabolites. A controlled trial of the Finnish Prostate Cancer Group. Eur J Cancer"},{"key":"CIT0042","first-page":"1074","volume":"73","author":"Blomqvist C","year":"1996","journal-title":"Markers of type I collagen degradation and synthesis in the monitoring of treatment response in bone metastases from breast carcinoma. Br J Cancer"},{"key":"CIT0043","first-page":"2907","volume":"60","author":"Blomqvist C","year":"1987","journal-title":"Response evaluation of bone metastases in mam-mary carcinoma. The value of radiology, scintigraphy and biochemical markers of bone metabolism. Cancer"},{"key":"CIT0044","first-page":"166","volume":"32","author":"Elomaa I","year":"1996","journal-title":"Monitoring the action of clodronate with type I collagen metabolites in multiple myeloma. Eur J Cancer"},{"key":"CIT0045","first-page":"1289","volume":"72","author":"Purohit OP","year":"1995","journal-title":"A randomized double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malig-nancy. Br J Cancer"},{"key":"CIT0046","first-page":"488","volume":"18","author":"Die IJ","year":"1999","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CIT0048","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1200\/JCO.1995.13.4.929","volume":"13","author":"O'Rourke N","year":"1995","journal-title":"J Clin Oncol"},{"key":"CIT0049","first-page":"2427","volume":"13","author":"Robertson AG","year":"1995","journal-title":"Ralston SH. Effect of oral do-dronate on metastatic bone pain: a double-blind, placebo-controlled study. J Clin Oncol"},{"key":"CIT0050","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0885-3924(92)90101-M","volume":"7","author":"Ernst DS","year":"1992","journal-title":"J Pain Symptom Manage"},{"key":"CIT0051","first-page":"a528","volume":"15","author":"Vinholes J","year":"1996","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CIT0052","first-page":"a469","volume":"17","author":"Lipton A","year":"1998","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CIT0053","first-page":"6","volume":"88","author":"Major PP","year":"2000","journal-title":"A review of clinical use in patients with bone metastases. Cancer"},{"key":"CIT0054","first-page":"222","volume":"27","author":"Pentikdinen PJ","year":"1989","journal-title":"Phar-macokinetics of clodronate in patients with metastatic breast cancer. Int .1- Pharmacol Ther Toxicol"},{"key":"CIT0055","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1359\/jbmr.1997.12.1.66","volume":"12","author":"Castren-Kortekangas P","year":"1997","journal-title":"J Bone Miner Res"},{"key":"CIT0056","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1200\/JCO.1997.15.1.110","volume":"15","author":"Liu G","year":"1997","journal-title":"J Clin Oncol"},{"issue":"1","key":"CIT0057","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/8756-3282(91)90066-R","volume":"12","author":"Bierman WA","year":"1991","journal-title":"Bone"},{"key":"CIT0059","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1046\/j.1365-2141.1999.01194.x","volume":"104","author":"Bruce NJ","year":"1999","journal-title":"Br J Haematol"},{"key":"CIT0060","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1200\/JCO.2000.18.1.72","volume":"18","author":"Hillner BE","year":"2000","journal-title":"J Clin Oncol"},{"key":"CIT0061","first-page":"295","volume":"300","author":"Pedersen-Bjergaard U","year":"1991","journal-title":"Severe hypocalcaemia after treatment of diphosphonate and aminoglycoside. Correspon-dence. Br Med J"},{"key":"CIT0062","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/oxfordjournals.annonc.a058530","volume":"4","author":"Mayordomo JI","year":"1993","journal-title":"Correspon-dence. Ann Oncol"},{"key":"CIT0064","first-page":"159","volume":"324","author":"Adamson BB","year":"1993","journal-title":"Lancet"}],"container-title":["Acta Oncologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/028418600750013357","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T18:04:04Z","timestamp":1756404244000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/view\/26750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":58,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2009,7,8]]},"published-print":{"date-parts":[[2000,1]]}},"alternative-id":["10.1080\/028418600750013357"],"URL":"https:\/\/doi.org\/10.1080\/028418600750013357","relation":{},"ISSN":["0284-186X","1651-226X"],"issn-type":[{"value":"0284-186X","type":"print"},{"value":"1651-226X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,1]]}}}